Robotics & Machine Learning Daily News2024,Issue(Sep.11) :38-38.

Second Xiangya Hospital of Central South University Reports Findings in Bladder Cancer (Establish TIIC signature score based the machine learning fusion in blad der cancer)

Robotics & Machine Learning Daily News2024,Issue(Sep.11) :38-38.

Second Xiangya Hospital of Central South University Reports Findings in Bladder Cancer (Establish TIIC signature score based the machine learning fusion in blad der cancer)

扫码查看

Abstract

By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Oncology - Bladder Can cer is the subject of a report. According to news originating from Hunan, People ’s Republic of China, by NewsRx correspondents, research stated, “Bladder cancer is a prevalent malignant tumor with high heterogeneity. Current treatments, suc h as transurethral resection of bladder tumor (TURBT) and intravesical Bacillus Calmette-Guerin (BCG) therapy, still have limitations, with approximately 30% of non-muscle-invasive bladder cancer (NMIBC) progressing to muscle-invasive bla dder cancer (MIBC), and a substantial number of MIBC patients experiencing recur rence after surgery.”

Key words

Hunan/People’s Republic of China/Asia/Bladder Cancer/Cancer/Cyborgs/Drugs and Therapies/Emerging Technologies/Ge netics/Health and Medicine/Immunotherapy/Machine Learning/Oncology

引用本文复制引用

出版年

2024
Robotics & Machine Learning Daily News

Robotics & Machine Learning Daily News

ISSN:
段落导航相关论文